Navigation Links
Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics

- Court Orders Confiscation of Diagnostica Stago's Inventory of Infringing Products -

BEDFORD, Mass., May 4 /PRNewswire/ -- Instrumentation Laboratory Company and its parent company Instrumentation Laboratory S.p.A. (IL) today announced that the Paris First Level Civil Court determined that Diagnostica Stago infringed the French counterparts of two European patents licensed exclusively to IL, and committed acts of unfair competition due to denigrating advertisements. As a result, the Court ruled in part that: 1) Diagnostica Stago must cease manufacturing and selling its infringing products, STA-Staclot APC-R kits and STAGEN Kit FVM Mutation, and must cease denigrating advertisements concerning IL's products, 2) Diagnostica Stago's inventory of STA-Staclot APC-R kits and STAGEN Kit FVM Mutation may be confiscated for potential future destruction, and 3) Diagnostica Stago must pay IL the sum of 2,000,000 euros (approximately $2,600,000 US) as an advance on damages for the infringement and unfair competition, plus attorneys' fees. The court's decision may be appealed.

IL is the exclusive licensee of two patents, EP 0 608 235 and EP 0 690 991, covering inventions from the world-renowned researcher, Dr. Bjorn Dahlback, relating to the detection of thrombophilia, a coagulation disorder, in human blood. The first patent relates to a method for diagnosing a human blood coagulation disorder called resistance to APC (also known as activated protein C resistance), while the second patent additionally relates to a method for determining the presence of gene mutations of Factor V, which is one of the causes of thrombophilia.

"Litigation is not our first preference. However, our belief that Diagnostica Stago violated our patent rights and unfairly advertised by disparaging IL's product, forced us to pursue legal action. We are pleased with the Court's decision," said Josep Manent, Chief Executive at IL. "Our excellent HemosIL and Chromogenix reagent product line offers a broad spectrum of diagnostic tests, including assays for the detection of APC resistance and factor V Leiden mutations. We are committed to providing current and future customers around the world with these tests, to ensure that all hemostasis labs have access to the very best diagnostic tools for the highest quality patient care."

IL offers tests for identifying resistance to APC, a cause of thrombophilia. Today, IL offers a comprehensive line of HemosIL reagents for the diagnosis of thrombophilia, including antithrombin, protein C, protein S, activated protein C resistance, factor V Leiden, homocysteine, ThromboPath, and Xpert HemosIL FII & FV molecular. Additionally, HemosIL reagents are available for the management of antiphospholipid syndrome, coagulation factors, von Willebrand disease, fibrinolysis, and general screening and anticoagulant monitoring. Coupled with the ACL family of instruments, IL brings automation to the hemostasis lab. IL is dedicated to providing constant innovation through the highest quality, fully integrated solutions.

Instrumentation Laboratory ( is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM product offerings, part of the critical care line, include the GEM Premier(TM) 4000 analyzer with Intelligent Quality Management (iQM), the new GEM Premier 3500 analyzer with iQM and the GEM PCL Plus(TM), a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP family of hemostasis testing systems, fully automated, high-productivity analyzers, including the ACL TOP and the new ACL TOP 500 CTS. IL also offers the ACL ELITE and ELITE PRO(TM), other hemostasis analyzers and the HemosIL line of reagents.

The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL, ACL TOP, ACL ELITE, ACL AcuStar, Premier and GEM OPL are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.

SOURCE Instrumentation Laboratory Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio
2. Instrumentation Laboratory Announces ILeader Panel of Experts as Part of 50th Anniversary Program
3. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
4. Instrumentation Laboratory Receives Performance Award from Premier for Second Consecutive Year
5. Instrumentation Laboratory Launches ACL Top(R) 500 CTS Hemostasis Testing System
6. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
7. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
8. PLUS Diagnostics Opens West Coast Laboratory to Support Increased Demand for Anatomic Pathology Services
9. Misonix Announces the Sale of Its Ultrasonic Laboratory Business for $3.5 Million to iSonix LLC
10. Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center
11. Covance Central Laboratory Receives CAP Accreditation in China
Post Your Comments:
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... Scientists in ... tissue biopsy in 18 patients with or without mesothelioma. Surviving Mesothelioma has just posted ... , The doctors from PhenoPath Laboratories in Seattle and the University of British Columbia ...
(Date:10/13/2015)... ... , ... Tempe Dental Care, a leading Tempe dentists’ office, celebrates offering gentle, ... for more than 5 years. A leading cause of emergency room visits, school ... is not timely. , Sedation dentistry provides an anxiety-free dental experience ...
(Date:10/13/2015)... ... , ... Local Gold’s Gym franchise owner, Bryce Berry, received the Visionary of ... owns and operates Gold's Gym Cheyenne in Cheyenne, Wyoming, received the award ... States. A brand leader in global fitness, Gold’s Gyms are located worldwide. Every fitness ...
(Date:10/13/2015)... ... October 13, 2015 , ... Thermi, an ... newest professional to introduce the latest development, ThermiVa® temperature controlled radiofrequency to the ... professional in Obstetrics and Gynecology and a pioneer in the field of laparoscopy. ...
(Date:10/13/2015)... ... October 13, 2015 , ... In an ongoing effort ... , a Southlake, Texas, child development and pediatric therapy center, is working with ... families about their options for receiving this kind of care for affected children. ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , October 13, 2015 ... World Thrombosis Day Interactive Infographic   --> ... World Thrombosis Day  to promote vital global awareness ... and symptoms. Thrombosis is the formation of potentially ... - resulting in venous thromboembolism (VTE) - or the ...
(Date:10/12/2015)... Given the intricacy of the anatomy and physiology of ... drug effectively to a specific ocular site. Several barriers have ... include dilution of a drug by tears, clearance of a ... issues with respect to the cornea, sclera and choroid. Approximately ... due to the aforementioned barriers. --> Given ...
(Date:10/12/2015)... 12, 2015  The Pharmacy Compounding Accreditation Board ... Pharmacy in Costa Mesa , ... the pharmacy,s commitment to meeting and/or exceeding national ... --> --> ... --> --> Harbor Compounding ...
Breaking Medicine Technology: